Answers are grounded in this paper and cite their sources.
IMMUNOTHERAPY with chemotherapy is emerging as a new standard first-line treatment in advanced endometrial cancer (EC). In an insightful session presented at this year’s European Society for Medical Oncology (ESMO) Congress, held in Barcelona, Spain from the 13th–17th September, experts in the field discussed what we know, and what we should know, on immunotherapy and EC.
No takes yet. Share an insight, caveat, or question.
Ada Enesco (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: